miR-146a and miR-155 delineate a MicroRNA fingerprint associated with Toxoplasma persistence in the host brain

Dominique Cannella1, Marie-Pierre Brenier-Pinchart1, Laurence Braun1

  • 1CNRS, UMR5163, LAPM, 38041 Grenoble, France; Université Joseph Fourier, 38000 Grenoble, France.

Cell Reports
|March 4, 2014
PubMed

Insights

Two microRNAs, miR-146a and miR-155, are key regulators in the host response to Toxoplasma infection. Their levels indicate infection strain, and miR-146a deficiency improves mouse survival.

Area of Science:

  • Immunology
  • Molecular Biology
  • Parasitology

Background:

  • MicroRNAs (miRNAs) are recognized regulators of host responses to parasitic infections.
  • Apicomplexan parasites, such as Toxoplasma gondii, pose significant health challenges globally.

Purpose of the Study:

  • To identify specific microRNAs involved in the host response to Toxoplasma infection.
  • To investigate the role of these microRNAs in strain-specific infection dynamics and host survival.

Main Methods:

  • Co-expression analysis of microRNAs in infected mouse brains.
  • Forward genetics to identify genetic mediators of microRNA regulation.
  • Assessment of parasite burden and host survival in genetically modified mice.

Main Results:

  • Two immunomodulatory microRNAs, miR-146a and miR-155, were co-induced in mouse brains during Toxoplasma infection.
  • These microRNAs serve as a molecular signature for type II Toxoplasma strains, prevalent in human infections.
  • The rhoptry kinase ROP16 partially mediates strain-specific miR-146a modulation.
  • miR-146a deficiency enhanced control of parasite burden and improved long-term survival in mice.

Conclusions:

  • miR-146a and miR-155 are critical regulators of the host immune response to Toxoplasma.
  • Strain-specific modulation of miR-146a by parasite factors like ROP16 influences infection outcome.
  • Targeting miR-146a represents a potential therapeutic strategy for toxoplasmosis.